283 related articles for article (PubMed ID: 27696308)
1. MicroRNA-200c modulates DUSP-1 expression in diabetes-induced cardiac hypertrophy.
Singh GB; Raut SK; Khanna S; Kumar A; Sharma S; Prasad R; Khullar M
Mol Cell Biochem; 2017 Jan; 424(1-2):1-11. PubMed ID: 27696308
[TBL] [Abstract][Full Text] [Related]
2. miR-30c Mediates Upregulation of Cdc42 and Pak1 in Diabetic Cardiomyopathy.
Raut SK; Kumar A; Singh GB; Nahar U; Sharma V; Mittal A; Sharma R; Khullar M
Cardiovasc Ther; 2015 Jun; 33(3):89-97. PubMed ID: 25781190
[TBL] [Abstract][Full Text] [Related]
3. miR-30c and miR-181a synergistically modulate p53-p21 pathway in diabetes induced cardiac hypertrophy.
Raut SK; Singh GB; Rastogi B; Saikia UN; Mittal A; Dogra N; Singh S; Prasad R; Khullar M
Mol Cell Biochem; 2016 Jun; 417(1-2):191-203. PubMed ID: 27221738
[TBL] [Abstract][Full Text] [Related]
4. DUSP-1 gene expression is not regulated by promoter methylation in diabetes-associated cardiac hypertrophy.
Singh GB; Khanna S; Raut SK; Sharma S; Sharma R; Khullar M
Ther Adv Cardiovasc Dis; 2017; 11(5-6):147-154. PubMed ID: 28413926
[TBL] [Abstract][Full Text] [Related]
5. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK/NF-κB signalling pathway.
Liu X; Guo B; Zhang W; Ma B; Li Y
J Biochem; 2021 Oct; 170(3):349-362. PubMed ID: 33837411
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice.
Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X
Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195
[TBL] [Abstract][Full Text] [Related]
7. Dihydromyricetin Prevents Diabetic Cardiomyopathy via miR-34a Suppression by Activating Autophagy.
Ni T; Lin N; Lu W; Sun Z; Lin H; Chi J; Guo H
Cardiovasc Drugs Ther; 2020 Jun; 34(3):291-301. PubMed ID: 32212062
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy.
Li X; Du N; Zhang Q; Li J; Chen X; Liu X; Hu Y; Qin W; Shen N; Xu C; Fang Z; Wei Y; Wang R; Du Z; Zhang Y; Lu Y
Cell Death Dis; 2014 Oct; 5(10):e1479. PubMed ID: 25341033
[TBL] [Abstract][Full Text] [Related]
9. Salusin-β contributes to oxidative stress and inflammation in diabetic cardiomyopathy.
Zhao MX; Zhou B; Ling L; Xiong XQ; Zhang F; Chen Q; Li YH; Kang YM; Zhu GQ
Cell Death Dis; 2017 Mar; 8(3):e2690. PubMed ID: 28333148
[TBL] [Abstract][Full Text] [Related]
10. Corin is down-regulated and exerts cardioprotective action via activating pro-atrial natriuretic peptide pathway in diabetic cardiomyopathy.
Pang A; Hu Y; Zhou P; Long G; Tian X; Men L; Shen Y; Liu Y; Cui Y
Cardiovasc Diabetol; 2015 Oct; 14():134. PubMed ID: 26446774
[TBL] [Abstract][Full Text] [Related]
11. Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1.
Yildirim SS; Akman D; Catalucci D; Turan B
Cell Biochem Biophys; 2013; 67(3):1397-408. PubMed ID: 23723006
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1/AMPK pathway.
Kuwabara Y; Horie T; Baba O; Watanabe S; Nishiga M; Usami S; Izuhara M; Nakao T; Nishino T; Otsu K; Kita T; Kimura T; Ono K
Circ Res; 2015 Jan; 116(2):279-88. PubMed ID: 25362209
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic overexpression of miR-92a-2-5p ameliorated cardiomyocyte oxidative stress injury in the development of diabetic cardiomyopathy.
Yu M; Sun Y; Shan X; Yang F; Chu G; Chen Q; Han L; Guo Z; Wang G
Cell Mol Biol Lett; 2022 Oct; 27(1):85. PubMed ID: 36209049
[TBL] [Abstract][Full Text] [Related]
14. MiR-30c/PGC-1β protects against diabetic cardiomyopathy via PPARα.
Yin Z; Zhao Y; He M; Li H; Fan J; Nie X; Yan M; Chen C; Wang DW
Cardiovasc Diabetol; 2019 Jan; 18(1):7. PubMed ID: 30635067
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of prolyl hydroxylase 3 ameliorates cardiac dysfunction in diabetic cardiomyopathy.
Xia Y; Gong L; Liu H; Luo B; Li B; Li R; Li B; Lv M; Pan J; An F
Mol Cell Endocrinol; 2015 Mar; 403():21-9. PubMed ID: 25595486
[TBL] [Abstract][Full Text] [Related]
16. Compromised diabetic heart function is not affected by miR-378a upregulation upon hyperglycemia.
Florczyk-Soluch U; Polak K; Sabo R; Martyniak A; Stępniewski J; Dulak J
Pharmacol Rep; 2023 Dec; 75(6):1556-1570. PubMed ID: 37851320
[TBL] [Abstract][Full Text] [Related]
17. Apocynin attenuates diabetic cardiomyopathy by suppressing ASK1-p38/JNK signaling.
Ding W; Feng H; Li WJ; Liao HH; Zhang N; Zhou ZY; Mou SQ; Lin Z; Xia-He NZ; Xia H; Tang QZ
Eur J Pharmacol; 2021 Oct; 909():174402. PubMed ID: 34348125
[TBL] [Abstract][Full Text] [Related]
18. Role of MicroRNA-34a in Anti-Apoptotic Effects of Granulocyte-Colony Stimulating Factor in Diabetic Cardiomyopathy.
Park IH; Song YS; Joo HW; Shen GY; Seong JH; Shin NK; Cho YJ; Lee Y; Shin JH; Lim YH; Kim H; Kim KS
Diabetes Metab J; 2020 Feb; 44(1):173-185. PubMed ID: 31237127
[TBL] [Abstract][Full Text] [Related]
19. High glucose induces Drp1-mediated mitochondrial fission via the Orai1 calcium channel to participate in diabetic cardiomyocyte hypertrophy.
Wu QR; Zheng DL; Liu PM; Yang H; Li LA; Kuang SJ; Lai YY; Rao F; Xue YM; Lin JJ; Liu SX; Chen CB; Deng CY
Cell Death Dis; 2021 Feb; 12(2):216. PubMed ID: 33637715
[TBL] [Abstract][Full Text] [Related]
20. MiR-29a regulates cardiomyocyte apoptosis by targeting Bak1 in diabetic cardiomyopathy.
Wang X; Zhang Z; Wang M
J Biochem; 2022 May; 171(6):663-671. PubMed ID: 35274138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
